Reduced Toxicity Conditioning Allogeneic Hematopoietic Cell Transplantation with Once Daily Intravenous Busulfan for Relapsed/Refractory Lymphoma – a Phase II Study
| Autor: | Steven Rollins, Chelby Wakefield, Michael Craig, Aaron Cumpston, Mehdi Hamadani, Abraham S. Kanate, Sijin Wen, Carl T. Shultz, Lauren Veltri, Kelly G. Ross |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Oncology
Transplantation medicine.medical_specialty Intravenous busulfan Hematopoietic cell business.industry Phases of clinical research Cell Biology Hematology medicine.disease Reduced toxicity conditioning Lymphoma Internal medicine Relapsed refractory medicine Molecular Medicine Immunology and Allergy Once daily business |
| Zdroj: | Transplantation and Cellular Therapy. 27:S228-S229 |
| ISSN: | 2666-6367 |
| DOI: | 10.1016/s2666-6367(21)00283-9 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect